Published date: 3 February 2022

Awarded contract - This means that the contract has been awarded to a supplier.


Closing: 20 January 2022, 12pm

Contract summary

Industry

  • Financial consultancy services - 66171000

Location of contract

United Kingdom

Value of contract

£213,477

Procurement reference

2370

Published date

3 February 2022

Closing date

20 January 2022

Closing time

12pm

Contract start date

4 February 2022

Contract end date

3 February 2025

Contract type

Service contract

Procedure type

Open procedure (below threshold)

Any interested supplier may submit a tender in response to an opportunity notice.

This procedure can be used for procurements below the relevant contract value threshold.

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

No

Description

CPI are looking to establish a consultancy framework for an advisor to provide expert contribution to the technology
transfer, process development, GMP Preparation and Commercial Manufacture of a self-amplifying RNA Vaccine, in
response to the COVID-19 Vaccine manufacture programme. CPI requires support with management of the UK supply
chain manufacture of 40 million self-amplifying RNA Vaccine doses, in response to the COVID-19 Vaccine manufacture
programme.

More information

Previous notice about this procurement

Framework for RNA Centre of Excellence Finance and Training Consultancy

  • Opportunity
  • Published 5 January 2022

Links

Award information

Awarded date

2 February 2022

Contract start date

2 February 2022

Contract end date

1 February 2026

Total value of contract

£177,897.50

This contract was awarded to 1 supplier.

222 Strategic Consultancy Ltd

Address

3 Cecilian Court
Cecilian Avenue
Worthing
West Sussex
BN14 8AP

Reference

Companies House number: 11932011

Supplier is SME?

Yes

Supplier is VCSE?

No

About the buyer

Contact name

CPI Procurement

Address

Wilton
REDCAR
TS104RF
England

Telephone

01740 625716

Email

e-tendering@uk-cpi.com